Eastman Chemical Company (EMN) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026, and the first six months of 2026. Eastman Chemical Company operates four segments: Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The company is a large accelerated filer with 114.4 million shares of common stock outstanding as of the reporting date.
Key Financial Metrics
| Metric | Q2 2026 | Q2 2025 | YTD 2026 | YTD 2025 |
|---|---|---|---|---|
| Sales (Revenue) | $2,513M | $2,287M | $4,690M | $4,577M |
| Gross Profit | $560M | $506M | $991M | $1,073M |
| Gross Margin | 22.3% | 22.1% | 21.1% | 23.4% |
| Net Earnings (Attributable to Eastman) | $183M | $140M | $290M | $322M |
| Diluted EPS | $1.59 | $1.20 | $2.51 | $2.77 |
| Operating Cash Flow (YTD) | $87M | $66M | $87M | $66M |
| Total Borrowings | $5,217M | $4,787M | $5,217M | $4,787M |
| Cash & Equivalents | $691M | $566M | $691M | $566M |
| Net Debt | $4,526M | $4,221M | $4,526M | $4,221M |
Material Changes vs. Prior Period
- Revenue Growth: Q2 2026 sales increased 10% year-over-year, driven by higher volume/mix in AM and CI segments and higher selling prices (partially due to Middle East conflict impacts). YTD sales rose 2% primarily due to favorable foreign exchange rates.
- Profitability: Q2 Net Earnings rose 31% to $183M. However, YTD Net Earnings declined 10% to $290M due to lower volume/mix, lower selling prices in certain segments, and higher raw material/energy costs.
- Segment Performance:
- Chemical Intermediates: Strongest performer with Q2 sales up 39% and EBIT turning positive ($58M) from a loss of $30M in Q2 2025.
- Fibers: Weakest performer with Q2 sales down 11% and EBIT down 56% due to inventory destocking and weak textile demand.
- Advanced Materials: Q2 EBIT declined 10% due to lower asset utilization and higher manufacturing costs.
- Debt Structure: Total borrowings increased to $5.2 billion following the issuance of $600M in 4.5% notes due 2031 in Q1 2026. The company repaid the remaining $150M of its 2027 Term Loan in Q1 2026.
- Tax Impact: The effective tax rate for Q2 2026 was 28%, impacted by the "One Big Beautiful Bill Act" (OBBBA) regarding R&D deductibility. Management forecasts a full-year adjusted effective tax rate of approximately 14.5%.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects 2026 CapEx to be approximately $400 million, focused on maintenance and limited strategic growth projects.
- Dividends: A quarterly dividend of $0.84 per share was declared for Q2 2026.
- Share Repurchases: No shares were repurchased in the first six months of 2026. The company maintains a $2.5 billion authorization (with $1.2 billion utilized as of June 30, 2026).
- Key Risks:
- Geopolitical: Ongoing conflict in the Middle East impacting raw material costs and pricing.
- Regulatory/Legal: Supreme Court rulings on IEEPA tariffs resulted in a $24M benefit recognized in YTD 2026. The company is appealing a terminated DOE grant for its recycling project.
- Market: Exposure to foreign currency fluctuations, commodity prices, and interest rates, managed through hedging programs.
Investor Verification Checklist
- Tax Rate Volatility: Verify the impact of the "One Big Beautiful Bill Act" on future R&D deductibility and the sustainability of the forecasted 14.5% adjusted tax rate.
- Segment Divergence: Monitor the widening performance gap between the Chemical Intermediates segment (strong) and the Fibers segment (weak) to assess portfolio balance.
- Working Capital: Review the $369M increase in trade receivables and $146M increase in inventories YTD 2026, which negatively impacted operating cash flow.
- Debt Maturity: Confirm the status of the $569M 1.875% notes due November 2026 and the company's refinancing or repayment strategy.
- Non-Core Items: Scrutinize the $21M in non-core charges (restructuring, environmental) excluded from Adjusted EBIT to understand core operational performance.